Ho KKY, Fleseriu M, Wass J, et al. A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol. 2024; 12: 209-214. Ž
Melmed S, Kaiser UB, Lopes MB, et al. Clinical biology of the pituitary adenoma. Endocr Rev. 2022; 43: 1003-1037. Ž
Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: a cross -sectional study in the province of Liège, Belgium. J Clin Endocrinol Metab. 2006; 91: 4769-4775. Ž
Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross -sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2010; 72: 377-382. Ž
Fontana Gaillard RE. Epidemiology of pituitary adenoma: results of the first Swiss study. Rev Med Suisse. 2009; 5: 2172-2174. Ž
Daly AF, Beckers A. The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am. 2020; 49: 347-355. Ž
Agustsson TT, Baldvinsdottir T, Jonasson JG, et al. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study. Eur J Endocrinol. 2015; 173: 655-664. Ž
Gruppetta M, Mercieca C, Vassallo J. Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary. 2013; 16: 545-553. Ž
Fainstein Day P, Loto MG, Glerean M, et al. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina. Arch Endocrinol Metab. 2016; 60: 554-561. Ž
Derwich-Rudowicz A, Kubiak KB, Wojciechowski K, et al. Clinically relevant pituitary adenomas: a single -center epidemiological study. Pol Arch Intern Med. 2025; 135: 17082. Ž
Giustina A, Uygur MM, Frara S, et al. Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary. 2024; 27: 381-388. Ž
